Akman, T. Et Al. 2015. Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]. Medical Oncology , vol.32 , 1-2.

Akman, T., Oztop, I., Baskin, Y., Akbarpour, M., Unal, O., Oflazoglu, U., ... Ellidokuz, H.(2015). Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]. Medical Oncology , vol.32, 1-2.

Akman, T. Et Al. "Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]," Medical Oncology , vol.32, 1-2, 2015

Akman, T. Et Al. "Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]." Medical Oncology , vol.32, pp.1-2, 2015

Akman, T. Et Al. (2015) . "Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]." Medical Oncology , vol.32, pp.1-2.

@article{article, author={T. Akman Et Al. }, title={Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy [Med Oncol, (2015), 32:440, 10.1007/s12032-014-0440-7]}, journal={Medical Oncology}, year=2015, pages={1-2} }